Invasive meningococcal disease continues to be a life-threatening condition and rapid diagnosis is important for the administration of appropriate treatment. This study focused on the use of PCR for the diagnosis of meningococcal aetiology and the dynamics of PCR-based diagnosis over time in various biological samples. Sixty cerebrospinal fluid (CSF) and 144 serum samples collected during the first week of hospitalisation from 37 patients with laboratory-confirmed invasive meningococcal disease were investigated. Overall, 91.9% of CSF samples and 45.9% of serum samples were PCR-positive, while culture of CSF and blood was positive for only 35% and 39% samples, respectively. Positive PCR results were obtained until day 7 with CSF and until day 5 with serum. It is therefore recommended that samples for molecular diagnosis should be collected early in the course of suspected invasive meningococcal disease.
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I N T R O D U C T I O N
Invasive disease (sepsis and ⁄ or meningitis) caused by Neisseria meningitidis is a potentially life-threatening condition that can also lead to life-long disfigurement. Clinical suspicion of this infection is usually based on the presence of haemorrhagic skin rash associated with symptoms of meningitis or acute sepsis. Rapid and accurate diagnosis is essential both for optimal management of patients and for timely antibiotic prophylaxis for contacts. Confirmation of the aetiological diagnosis allows physicians to use narrow-spectrum antibiotics, to shorten the duration of treatment and to provide prognostic information.
Conventional microscopy, as well as culture methods, may fail to allow the diagnosis of invasive meningococcal disease (IMD) because of early administration of antibiotics. Blood cultures are positive in c. 50% of untreated patients with meningococcal sepsis, but this positivity rate is reduced to 5% after the first dose of antibiotic. Similarly, microscopy or culture is positive with cerebrospinal fluid (CSF) samples in 90% of untreated cases of meningococcal meningitis, but there is a dramatic reduction if antibiotics have been administered previously [1] . PCR detects small quantities of bacterial DNA and does not require the presence of viable bacteria. Therefore, it can confirm the aetiological agent even after antibiotic administration. Moreover, PCR can determine the serogroup of meningococci involved. Serogroup classification of meningococcal isolates is useful for epidemiological surveillance, for case ⁄ contact management, and for monitoring the effectiveness of meningococcal vaccines. Detection of meningococcal DNA in biological samples has been achieved with primers based on the 16S rRNA gene [2, 3] , and more specific primers can be used for serogroup identification (siaD gene for serogroups B, C, Y and W135, and mynB ⁄ sacC gene for serogroup A) [4, 5] . Fluorescence-and gel-based methods have been developed for visualisation and identification of PCR products [6] [7] [8] .
In the Czech Republic, an active surveillance programme registers c. 100 cases of IMD annually, with a reported case fatality rate of c. 10% [9] . Since 2001, PCR has been used increasingly for laboratory confirmation and epidemiological surveillance of IMD in the Czech Republic. In 2003, the aetiology of 41.6% of all registered cases of IMD was confirmed by PCR. Moreover, PCR was the only method that enabled the aetiology to be confirmed for 17.8% of cases [10] . Since 2003, guidelines for pre-hospital management of suspected cases of IMD in the Czech Republic have recommended intravenous administration of the first dose of antibiotic and corticosteroid before transport to the hospital, with blood for culture and PCR being taken before treatment is started [11] . Conflicting findings have been published concerning the dynamics of bacterial DNA stability in various biological samples. This information could contribute to a better understanding of the pathophysiology of IMD, as well as indicating the most appropriate time for taking samples. The aim of the present study was to determine the dynamics of PCR-based diagnosis in blood and CSF samples, and to compare the efficacies of different PCR primer pairs.
M A T E R I A L S A N D M E T H O D S Patients
The individuals included in this prospective study were patients with positive PCR results from CSF and ⁄ or blood, hospitalised at the Department of Infectious Diseases of the University Hospital, Prague, between January 2002 and March 2004, who fulfilled one of the following criteria: (1) culture isolation of N. meningitidis from a normally sterile site (n = 20); or (2) typical clinical symptoms and positive latex agglutination (LA) test or direct microscopy (n = 5); or (3) typical clinical symptoms and no other aetiological agent confirmed (n = 12). Typical clinical symptoms were defined as: haemorrhagic skin rash (petechiae and ecchymoses) and presence of symptoms of sepsis ⁄ septic shock and ⁄ or meningitis. According to these criteria, 37 patients (20 males, 17 females; mean age 23.1 years; range 6 months to 58 years) were included in the study. Nine (24%) patients were diagnosed with sepsis and 28 (76%) with meningitis.
Collection and handling of specimens
For PCR, serum or whole blood samples were taken on the day of admission and during the first week of hospitalisation. CSF was collected on the day of admission and usually on day 5 after admission, or earlier if the patient's condition was not improving as expected. Sixty CSF samples and 144 blood samples were collected from 37 patients. Blood samples were stored at 4°C and CSF samples at ) 20°C. On the day of admission, biological material was sampled for direct microscopy, culture and LA tests. Antibiotic therapy was started on the day of admission or before hospitalisation. The day when therapy was started was recorded as day 0. Following admission, all patients were treated under standard regimens with cefotaxime or benzylpenicillin. Clinical data were obtained from medical reports and the physicians involved in treatment. Informed consent was received from the parents or guardians of all patients. The research was carried out in accordance with the Helsinki Declaration.
PCR
DNA was extracted from blood or serum (200 lL) and the sediment was obtained following centrifugation of c. 1 mL of CSF with a QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany). Primers used for PCR are listed in Table 1 ; crgA and nested 16S rRNA primers were used to detect N. meningitidis, and siaD primers were used to identify serogroups B and C. Reaction mixtures (50 lL) consisted of 10 mM Tris-HCl (pH 8.8), 50 mM KCl, Triton X-100 0.1% v ⁄ v, 1.5 mM MgCl 2 , 0.2 mM dNTPs (Biogen, Prague, Czech Republic), 0.5 lM primers, 0.5 U of recombinant Taq DNA polymerase (Top-Bio, Prague, Czech Republic) and 25 lL of DNA extract. Amplification was performed in an Amplitron II Thermocycler (Thermolyne, Dubuque, IA, USA) as follows: 94°C for 2 min, followed by 35 cycles of 94°C for 1 min, 55°C 5¢-CAATCACGATTTGCCCAATTGAC-3¢ Semi-nested
Step
for 1 min and 72°C for 1 min, followed by 72°C for 2 min. This first-step reaction was then diluted 1:500 in sterile, DNA-free water, and 5 lL was added to a second reaction, which consisted of 20 cycles. Each PCR run included negative (water) and positive controls. The PCR products were visualised under UV light following electrophoresis on agarose 2% w ⁄ v gels and staining with ethidium bromide. Amplicon sizes are listed in Table 1 .
Conventional identification
CSF and blood samples from patients with suspected IMD were sent to the microbiological laboratory for direct microscopy and culture. N. meningitidis strains were cultured on blood agar plates at 37°C in CO 2 5% v ⁄ v for 48 h. Commercially available LA kits were used for direct testing of CSF (Slides méningite-Kit 5; bioMérieux, Marcy l'Etoile, France) and blood (Pastorex meningitis kit; Bio-Rad, Marnesla-Coquette, France) with one drop (30-40 lL) of biological sample according to the manufacturers' instructions.
Statistical analysis
Results of diagnostic methods were expressed as percentages.
Results of tests performed before and after the onset of antibiotic treatment were compared using Fisher's exact test and GraphPad Prism v. 4.00 (Graph Pad Software, San Diego, CA, USA). The level of statistical significance was defined as p £ 0.05.
R E S U L T S
Positive PCR results were obtained for 17 (45.9%) blood samples and 34 (91.9%) CSF samples. In 15 (40%) cases, positive results were obtained with both sample types. Based on the PCR results, the infecting organisms belonged to serogroup B (n = 17; 46%), serogroup C (n = 15; 41%) or serogroup Y (n = 1; 3%), or else the serogroup was not determined (n = 4; 10%). Twenty (54%) patients had received antibiotics before collection of blood for PCR, and 16 (43%) patients received antibiotics before collection of CSF samples. In contrast to PCR, there were 14 (39%) positive blood cultures and 13 (35%) positive CSF cultures. Ten (28%) patients received antibiotics before collection of blood for culture, and 14 (38%) received antibiotics before collection of CSF for culture. In the group of pretreated patients, there was a significant reduction in the frequency of culture-positive results (p 0.01) and a nonsignificant reduction in the frequency of LApositive results. The frequency of positive PCR results was not changed significantly. The results obtained are summarised in Table 2 .
The aetiology of meningococcal disease was confirmed by PCR, culture and LA for 14 (38%) patients, by PCR and culture for nine (24%) patients, and by PCR and LA for two (5%) patients. For 12 (32%) patients, PCR was the only method that yielded a positive result. Table 3 summarises the relationship between the test results and the form of meningococcal disease (i.e., sepsis or meningitis).
Figs 1 and 2 illustrate the period following initiation of antibiotic treatment after which positive PCR results were obtained with CSF and blood samples. The last positive CSF sample was detected on day 7 (Fig. 1) , while the last positive blood sample was detected on day 5 (Fig. 2) . Meningococcal DNA was detected by the groupspecific primers until day 7 in CSF, and until day 2 in blood. With semi-nested PCR, positive results were obtained until day 6 in CSF, and until day 5 in blood. The low number of samples did not permit statistical evaluation of these results.
D I S C U S S I O N
A PCR method for detection of N. meningitidis serogroups B and C [4] was introduced in 2000 by the National Reference Laboratory for Meningo- For CSF, only the first samples collected on the day of admission were included. A combination of one-step and semi-nested PCR was used. Table 3 . Positive results of PCR, latex agglutination (LA) and culture for cerebrospinal fluid (CSF) and blood samples, grouped in relation to the clinical form of invasive meningococcal disease coccal Infections, Prague, and provides high sensitivity (85%) and specificity (95%) [12] . The original method was modified as described by Zambardi et al. [13] and makes use of the primers described by Frosh et al. [14] . Subsequently, the method has been upgraded to detect simultaneously N. meningitidis, Streptococcus pneumoniae and Haemophilus influenzae [2, 15] . In 2003, the National Reference Laboratory participated in an inter-laboratory comparison of PCR-based identification of N. meningitidis, which achieved a mean sensitivity and specificity of 90% and 93%, respectively [16] . The combined PCR method used in the present study was more reliable than culture and LA for the diagnosis of IMD. In 12 (32%) cases, the aetiology was identified only by PCR. Three cases were confirmed subsequently by multilocus sequence typing direct from CSF [17] . The other nine cases displayed the typical clinical course of the disease and no other agent was detected. The present study confirms the importance of PCR for identifying the aetiology in cases of IMD, with a significant increase in the number of laboratoryconfirmed cases of meningococcal disease. Almost half the patients in the present study received antibiotics before hospital admission, and PCR was particularly useful with such patients.
Previous studies have reported variable findings on the duration of detection by PCR of meningococcal DNA after antibiotic treatment. Ragunathan et al. [18] reported that blood and CSF were PCR-positive for 24 h and 72 h, respectively, after the start of antibiotic therapy, while Bryant et al. [19] obtained positive nested and real-time PCR results with blood samples up to day 9 after the start of intravenous antibiotics. The present study detected meningococcal DNA up to day 7 in CSF, and up to day 5 in blood after the start of antibiotic therapy. The results reflect the fact that DNA persists after bacteria have been killed, and that clearance of meningococcal DNA from CSF is slower than from blood. Differences in results among these studies may be explained by several factors, including: (1) the number of bacteria in CSF at the beginning of treatment; (2) the susceptibility of bacteria to antibiotics; (3) the number and killing activity of leukocytes in CSF (leukocytes destroy bacterial DNA after phagocytosis and bacterial lysis); and (4) the permeability of the blood-brain barrier, which influences penetration of antibiotics and the immune reaction components, as well as clearance of bacterial residues. As the overall detection rate for PCR decreases during the course of disease, it is recommended that biological samples (especially CSF) be taken for PCR investigation as soon as possible. Nevertheless, despite the availability and usefulness of PCR for identifying the aetiology in cases of IMD, culture of CSF and blood remains indispensable for antibiotic sensitivity testing and for further detailed research into strains of meningococci. 
